Molecular cloning and characterization of human FGF8 alternative messenger RNA forms

Cell Growth and Differentiation

Volumn 7, Issue 10, 1996, Pages 1425-1434

  Ghosh, Ananta K ^a   Shankar, Deepa B ^a,b   Shackleford, Gregory M ^a,b   Wu, Kai ^a,b   T'Ang, Anne ^a,b   Miller, Gary J ^c   Zheng, Jianping ^a   Roy Burman, Pradip ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CELL STRAIN 3T3; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTORS; GENE TRANSFER TECHNIQUES; GROWTH SUBSTANCES; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE ALIGNMENT; TUMOR CELLS, CULTURED;

ANIMALIA; EUKARYOTA; MURINAE; MUS MUSCULUS;

EID: 0029831216     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Basilico, C., and Moscatelli, D. The FGF family of growth factors and oncogenes. Adv. Cancer Res., 59: 115-165, 1992.
2. Johnson, D. E., and Williams, L. T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60: 1-41, 1993.
3. Mason, I. J. The ins and outs of fibroblast growth factors. Cell, 78: 546-552, 1994.
4. Tanaka, A., Miyamoto, K., Minamino, N., Takeda, M., Sato, B., Matsuo, H., and Matsumoto, K. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc. Natl. Acad. Sci. USA, 89: 8928-8932, 1992.
5. MacArthur, C. A., Lawshé, A., Xu, J., Santos-Ocampo, S., Heikinheimo, M., Chellaiah, A. T., and Ornitz, D. M. FGF-8 isoforms activate receptor splice forms that are expressed in meserchymal regions of mouse development. Development (Camb.), 121: 3603-3613, 1995.
6. MacArthur, C. A., Shankar, D. B., and Shackleford, G. M. FGF-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J. Virol., 69: 2501-2507, 1995.
7. Crossley, P. H., and Martin, G. R. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development (Camb.), 121: 439-451, 1995.
8. Kouhara, H., Koga, M., Kasayama, S., Tanaka, A., Kishimoto, T., and Sato, B. Transforming activity of a newly cloned androgen-induced growth factor. Oncogene, 9: 455-462, 1994.
9. MacArthur, C. A., Lawshé, A., Shankar, D. B., Heikinheimo, M., and Shackleford, G. M. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth & Differ., 6: 817-825, 1995.
10. Lorenzi, M. V., Long, J. E., Miki, T., and Aaronson, S. A. Expression cloning, developmental expression and chromosomal localization of fibroblast growth factor-8. Oncogene, 10: 2051-2055, 1995.
11. Catalona, W. J. Drug therapy: management of cancer of the prostate. N. Engl. J. Med., 331: 996-1004, 1994.
12. Isaacs, J. T., Lundmo, P. I., Berges, R., Martikainen, P., Kyprianou, N., and English, H. F. Androgen regulation of programmed death of normal and malignant prostatic cells. J. Androl., 13: 457-464, 1992.
13. Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. J. G., Brooks, J. D., and Ewing, C. M. Molecular biology of prostate cancer. Semin. Oncol., 21: 514-521, 1994.
14. Crawford, E. D., Eisenberger, M. A., McLeod, D. C., Spaulding, J., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., and Goodman, P. J. A control randomized trial of Leuprolide with and without flutamide in prostate cancer. N. Engl. J. Med., 321: 419-424, 1989.
15. Tanaka, A., Miyamoto, K., Matsuo, H., Matsumoto, K., and Yoshida, H. Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties. FEBS Lett., 363: 226-230, 1995.
16. Xu, H-J., Sumaji, J., Hu, S. X., Banerjee, A., Uzvolgyi, E., Klein, G., and Benedict, W. F. Intraocular tumor formation of Rb reconstituted retinoblastoma cells. Cancer Res., 51: 4481-4485, 1991.
17. Fung, Y-K., T'Ang, A., Murphee, A. L., Zhang, F-H., Qiu, W-R., Wang, S-W., Shi, X-H., Lee, L., Driscoll, B., and Wu, K-J. The Rb gene suppresses the growth of normal cells. Oncogene, 8: 2659-2672, 1993.
18. Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C., Trapman, J., Brinkmann, A. O., and Mulder, E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun., 173: 534-540, 1990.
19. Berrevoets, C. A., Veldschotte, J., and Mulder, E. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors. J. Steroid Biochem. Mol. Biol., 46: 731-736, 1993.
20. Bellosta, P., Talarico, D., Rogers, D., and Basilico, C. Cleavage of K-FGF produces a truncated molecule with increased biological activity and receptor binding affinity. J. Cell Biol., 121: 705-713, 1993.
21. Ron, D., Bortaro, D. P., Finch, P. W., Morris, D., Rubin, J. S., and Aaronson, S. A. Expression of biologically active recombinant keratinocyte growth factor. J. Biol. Chem., 268: 2984-2988, 1993.
22. Leung, H. Y., Dickson, C., Robson, C. N., and Neal, D. E. Over-expression of fibroblast growth factor-8 in human prostate cancer. Oncogene, 12; 1833-1835, 1996.
23. Miller, G. J., Stapleton, G. E., Hedlund, T. E., and Moffat, K. A. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1α, 25-diydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin. Cancer Res., 1: 997-1003, 1995.
24. Lee, M-S., Garkovenko, E., Yun, J. S., Weijerman, P. C., Peehl, D. M., Chen, L-S., and Rhim, J. S. Characterization of adult human prostatic cells immortalized by polybrene-induced DMA transfection with a plasmid containing an origin-defective SV40 genome. Int. J. Oncol., 4: 821-830, 1994.
25. Aviv, H., and Leder, P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Natl. Acad. Sci. USA, 69: 1408-1412, 1973.
26. Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., and Roe, B. A. Cloning in single-stranded bacteriophage as an aid to rapid DMA sequencing. J. Mol. Biol., 143: 161-178, 1980.
27. Ghosh, A. K., and Roy-Burman, P. Characterization of enhancer elements and their mutations in the long terminal repeat of feline endogenous RD-114 proviruses. J. Virol., 63: 4234-4241.
28. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.